Malaria Treatment Shows Promise in Treating COVID-19

Packets of a Nivaquine tablets containing chloroquine and Plaqueril, tablets containing hydroxychloroquine, drugs that have shown signs of effectiveness against the CCP virus, at the IHU Mediterranee Infection Institute in Marseille, France, on Feb. 26, 2020. Gerard Julien/AFP via Getty Images

A drug usually used to treat malaria showed promise in treating patients with COVID-19, the disease caused by the CCP virus.

French researchers gave hydroxychloroquine to 20 patients daily and all eventually recovered from the disease, which is caused by the novel coronavirus, or SARS-CoV-2. Combining hydroxychloroquine with another drug, azithromycin, had an even greater effect on the patients, the researchers wrote in their final report (pdf).